Israel - hebraico - Ministry of Health

ferring pharmaceuticals ltd - triptorelin as embonate - suspension for injection - triptorelin as embonate 11.25 mg - triptorelin - triptorelin - prostatic cancer and lowering of sexual hormones.

Israel - hebraico - Ministry of Health

ferring pharmaceuticals ltd - triptorelin acetate - תמיסה להזרקה - triptorelin acetate 0.1 mg/ml - triptorelin - triptorelin - precocius puberty, prostatic cancer, endomethriosis, uterus myomatoses and ivf.

Israel - hebraico - Ministry of Health

inovamed ltd - bicalutamide - טבליות מצופות פילם - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0), bicalutamide 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable

Israel - hebraico - Ministry of Health

j-c health care ltd - apalutamide - טבליות מצופות פילם - apalutamide 60 mg - apalutamide

Israel - hebraico - Ministry of Health

ferring pharmaceuticals ltd - triptorelin as embonate - אבקה וממס להכנת תרחיף להזרקה - triptorelin as embonate 22.5 mg - triptorelin

Israel - hebraico - Ministry of Health

astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 100 mg - olaparib

Israel - hebraico - Ministry of Health

astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 100 mg - olaparib

Israel - hebraico - Ministry of Health

astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 150 mg - olaparib

Israel - hebraico - Ministry of Health

astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 150 mg - olaparib

Israel - hebraico - Ministry of Health

organon pharma israel ltd., israel - follitropin beta - תמיסה להזרקה - follitropin beta 833 iu / 1 ml - follitropin beta - follitropin beta - puregon is indicated for the treatment of female infertility in the following clinical situations: anovulation (including polycystic ovarian disease, pcod) in women who have beenunresponsive to treatment with clomiphene citrate. controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [ e.g. in vitro fertilisation/embryo transfer (ivf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)]. in the male : deficient spermatogenesis due to hypogonadotrophic hypogonadism.